Pages that link to "Q28363020"

The following pages link to In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats (Q28363020):

Displaying 19 items.

• Serotonergic Modulation of Intrinsic Functional Connectivity (Q23992194) (← links)
• Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry (Q24610274) (← links)
• Neonatal citalopram exposure decreases serotonergic fiber density in the olfactory bulb of male but not female adult rats (Q28382837) (← links)
• Chronic antidepressant treatment impairs the acquisition of fear extinction (Q30437449) (← links)
• R-citalopram functionally antagonises escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter (Q35047103) (← links)
• Dose-dependent effects of neonatal SSRI exposure on adult behavior in the rat. (Q35585165) (← links)
• Lasting neurobehavioral abnormalities in rats after neonatal activation of serotonin 1A and 1B receptors: possible mechanisms for serotonin dysfunction in autistic spectrum disorders (Q37600851) (← links)
• Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats (Q41891465) (← links)
• Stereoselective single-dose kinetics of citalopram and its metabolites in rats (Q42164280) (← links)
• Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs (Q42461849) (← links)
• Effects of chronic citalopram treatment on central and peripheral spontaneous open-field behaviours in rats (Q42686745) (← links)
• Sustained citalopram treatment in experimental hepatic encephalopathy: effects on entrainment to the light-dark cycle and melatonin (Q42692737) (← links)
• Routine Therapeutic Drug Monitoring in Patients Treated with 10-360 mg/day Citalopram (Q44595729) (← links)
• Involvement of serotonin 5-HT3 receptors in the modulation of noradrenergic transmission by serotonin reuptake inhibitors: a microdialysis study in rat brain (Q45242499) (← links)
• Influence of quinidine, fluvoxamine, and ketoconazole on the enantioselective pharmacokinetics of citalopram in rats. (Q46244540) (← links)
• Reference Brain/Blood Concentrations of Citalopram, Duloxetine, Mirtazapine and Sertraline (Q47914522) (← links)
• Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: behavioral, biochemical, and electrophysiological evidence. (Q50062569) (← links)
• Cytochrome p450‐dependent disposition of the enantiomers of citalopram and its metabolites: In vivo studies in Sprague‐Dawley and Dark Agouti rats (Q51541896) (← links)
• Enantioselective analysis of citalopram and demethylcitalopram in human and rat plasma by chiral LC-MS/MS: Application to pharmacokinetics (Q62539051) (← links)